Add this topic to your myFT Digest for news straight to your inbox
Widespread testing for this treatable if embarrassing condition is being hampered by lack of access to healthcare
Novo Nordisk and Eli Lilly, plus a clutch of rivals, aim to cut side effects while treating obesity-linked diseases
Not only is the cost-benefit ratio unbeatable, but not to undertake this spending is to court disaster
Aardvark Therapeutics’ drug has been shown in trials to suppress cravings in patients with rare genetic form of obesity
Chemotherapy can target microscopic cells to prevent the disease from spreading
Four years after lockdowns began we are still learning about pandemic hangovers
Royal shares diagnosis after weeks of speculation over her long absence from public
Funding needed to drive innovation and make therapies available to all, says co-discoverer Jennifer Doudna
Lenmeldy gene therapy treats MLD, a condition that attacks the central nervous system of young children
Ruth McKernan aims to make country a hub for research into the condition and accelerate development of new drugs
Officials warn weaknesses in surveillance will hinder vaccine development as countries struggle to agree accord
Worldwide study finds neurological conditions affect billions as life expectancy rises
Researchers use machine learning to discover that ‘junk DNA’ may play pivotal role in development of tumours
We risk forgetting the lessons of the Covid pandemic
Cultivation of stem cells extracted from amniotic fluid will help treat congenital conditions
New Pasteur Institute head highlights risks posed by shortages of money, staff and political goodwill
GHO Capital has put contract research group FairJourney Biologics up for sale
Pharmaceutical companies scale back development in aftermath of pandemic
Research shows urgent need for policies to encourage weight loss and cut disease risk
‘Brain fog’ detectable in long and short-term cases, detailed study suggests
US biotech group’s data suggests dominance of Novo Nordisk and Eli Lilly in the anti-obesity segment could be challenged in a few years
German pharma group finds no unexpected side effects during trial, including at higher doses
I now understand why families cluster together under attack, so they can live or die as one
Baseimmune aims to predict future pathogen mutations to create jabs that will be effective for longer
Infections quadruple from last year after warnings that warming temperatures will increase cases
UK Edition